Neutra Corp. SEC filings NTRR
Neutra Corp. has 160 filings in SEC EDGAR's recent list, going back to Feb 24, 2011. Its latest annual report, Form 10-K, was filed on Aug 2, 2024 for the period ended Jan 31, 2024. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2024, covering the quarter ended Apr 30, 2024. The most recent current report (Form 8-K) was filed on May 15, 2024 (auditor change). The company's fiscal year ends on January 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14C | Schedule 14c preliminary information statement | Sep 24, 2019 | Sep 24, 2019 |
| DEF 14A | Proxy statement | Aug 11, 2015 | Aug 13, 2015 |
| PRE 14A | Preliminary proxy statement | Jul 31, 2015 | Jul 31, 2015 |
Showing 3 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NTRR (OTC)
- Fiscal year ends
- January 31
- Incorporated in
- WY
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1512886
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.